We offer our clients the utilization of our highly efficient in-house developed heterologous expression systems based on Actinomyces and Bacillus high-producing strains to service your needs, including the heterologous expression of gene clusters encoding complex biosynthesis of secondary metabolites, as well as heterologous protein expression, optimized for production of biopharmaceuticals or industrially relevant enzymes.
